Marie Ary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marie Ary has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
P Lomax
5 shared publicationsB Cox
3 shared publicationsAnirban Kundu
Xencor, 111 West Lemon Avenue, Monrovia, CA 91016
2 shared publications- Bassil I. Dahiyat
Xencor, Inc., Monrovia, California 91016, USA
2 shared publications Jonathan M. Jacinto
Xencor, 111 West Lemon Avenue, Monrovia, CA 91016
2 shared publicationsMarian Y. Hwang
Xencor, 111 West Lemon Avenue, Monrovia, CA 91016
2 shared publications
Latest Publications
- Open Access
- 13 August 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (33) , 16367-16377
Protein stability engineering insights revealed by domain-wide comprehensive mutagenesis
The accurate prediction of protein stability upon sequence mutation is an important but unsolved challenge in protein engineering. Large mutational datasets are required to train computational predictors, but traditional methods for collecting stability data are either low-throughput or measure protein stability indirectly. Here, we develop an automated method to generate thermodynamic stability data for nearly every single mutant in a small 56-residue protein. Analysis reveals that most single mutants have a neutral effect on stability, mutational sensitivity is largely governed by residue burial, and unexpectedly, hydrophobics are the best tolerated amino acid type. Correlating the output of various stability-prediction algorithms against our data shows that nearly all perform better on boundary and surface positions than for those in the core and are better at predicting large-to-small mutations than small-to-large ones. We show that the most stable variants in the single-mutant landscape are better identified using combinations of 2 prediction algorithms and including more algorithms can provide diminishing returns. In most cases, poor in silico predictions were tied to compositional differences between the data being analyzed and the datasets used to train the algorithm. Finally, we find that strategies to extract stabilities from high-throughput fitness data such as deep mutational scanning are promising and that data produced by these methods may be applicable toward training future stability-prediction tools.
- 13 August 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (33) , 16367-16377
Open AccessProtein stability engineering insights revealed by domain-wide comprehensive mutagenesis
The accurate prediction of protein stability upon sequence mutation is an important but unsolved challenge in protein engineering. Large mutational datasets are required to train computational predictors, but traditional methods for collecting stability data are either low-throughput or measure protein stability indirectly. Here, we develop an automated method to generate thermodynamic stability data for nearly every single mutant in a small 56-residue protein. Analysis reveals that most single mutants have a neutral effect on stability, mutational sensitivity is largely governed by residue burial, and unexpectedly, hydrophobics are the best tolerated amino acid type. Correlating the output of various stability-prediction algorithms against our data shows that nearly all perform better on boundary and surface positions than for those in the core and are better at predicting large-to-small mutations than small-to-large ones. We show that the most stable variants in the single-mutant landscape are better identified using combinations of 2 prediction algorithms and including more algorithms can provide diminishing returns. In most cases, poor in silico predictions were tied to compositional differences between the data being analyzed and the datasets used to train the algorithm. Finally, we find that strategies to extract stabilities from high-throughput fitness data such as deep mutational scanning are promising and that data produced by these methods may be applicable toward training future stability-prediction tools.
- Open Access
- 25 March 2018
- Published by Wiley in Protein Science
- Vol. 27 (6) , 1113-1124
ProtaBank: A repository for protein design and engineering data
We present ProtaBank, a repository for storing, querying, analyzing, and sharing protein design and engineering data in an actively maintained and updated database. ProtaBank provides a format to describe and compare all types of protein mutational data, spanning a wide range of properties and techniques. It features a user‐friendly web interface and programming layer that streamlines data deposition and allows for batch input and queries. The database schema design incorporates a standard format for reporting protein sequences and experimental data that facilitates comparison of results across different data sets. A suite of analysis and visualization tools are provided to facilitate discovery, to guide future designs, and to benchmark and train new predictive tools and algorithms. ProtaBank will provide a valuable resource to the protein engineering community by storing and safeguarding newly generated data, allowing for fast searching and identification of relevant data from the existing literature, and exploring correlations between disparate data sets. ProtaBank invites researchers to contribute data to the database to make it accessible for search and analysis. ProtaBank is available at https://protabank.org.
- 25 March 2018
- Published by Wiley in Protein Science
- Vol. 27 (6) , 1113-1124
Open AccessProtaBank: A repository for protein design and engineering data
We present ProtaBank, a repository for storing, querying, analyzing, and sharing protein design and engineering data in an actively maintained and updated database. ProtaBank provides a format to describe and compare all types of protein mutational data, spanning a wide range of properties and techniques. It features a user‐friendly web interface and programming layer that streamlines data deposition and allows for batch input and queries. The database schema design incorporates a standard format for reporting protein sequences and experimental data that facilitates comparison of results across different data sets. A suite of analysis and visualization tools are provided to facilitate discovery, to guide future designs, and to benchmark and train new predictive tools and algorithms. ProtaBank will provide a valuable resource to the protein engineering community by storing and safeguarding newly generated data, allowing for fast searching and identification of relevant data from the existing literature, and exploring correlations between disparate data sets. ProtaBank invites researchers to contribute data to the database to make it accessible for search and analysis. ProtaBank is available at https://protabank.org.
- 1 February 2018
- Published by Elsevier in Biophysical Journal
- Vol. 114 (3) , 411a-411A
PEBank: A Comprehensive Database for Protein Engineering and Design
- 1 February 2018
- Published by Elsevier in Biophysical Journal
- Vol. 114 (3) , 411a-411A
PEBank: A Comprehensive Database for Protein Engineering and Design
- 1 August 2005
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (15) , 1065-1071
Data management solutions for protein therapeutic research and development
- 1 August 2005
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (15) , 1065-1071
Data management solutions for protein therapeutic research and development
- 1 January 2004
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (2) , 82-90
Minimizing the immunogenicity of protein therapeutics
- 1 January 2004
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (2) , 82-90
Minimizing the immunogenicity of protein therapeutics
- Open Access
- 21 November 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (25) , 15926-15931
Combining computational and experimental screening for rapid optimization of protein properties
We present a combined computational and experimental method for the rapid optimization of proteins. Using β-lactamase as a test case, we redesigned the active site region using our Protein Design Automation technology as a computational screen to search the entire sequence space. By eliminating sequences incompatible with the protein fold, Protein Design Automation rapidly reduced the number of sequences to a size amenable to experimental screening, resulting in a library of ≈200,000 mutants. These were then constructed and experimentally screened to select for variants with improved resistance to the antibiotic cefotaxime. In a single round, we obtained variants exhibiting a 1,280-fold increase in resistance. To our knowledge, all of the mutations were novel, i.e., they have not been identified as beneficial by random mutagenesis or DNA shuffling or seen in any of the naturally occurring TEM β-lactamases, the most prevalent type of Gram-negative β-lactamases. This combined approach allows for the rapid improvement of any property that can be screened experimentally and provides a powerful broadly applicable tool for protein engineering.
- 21 November 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (25) , 15926-15931
Open AccessCombining computational and experimental screening for rapid optimization of protein properties
We present a combined computational and experimental method for the rapid optimization of proteins. Using β-lactamase as a test case, we redesigned the active site region using our Protein Design Automation technology as a computational screen to search the entire sequence space. By eliminating sequences incompatible with the protein fold, Protein Design Automation rapidly reduced the number of sequences to a size amenable to experimental screening, resulting in a library of ≈200,000 mutants. These were then constructed and experimentally screened to select for variants with improved resistance to the antibiotic cefotaxime. In a single round, we obtained variants exhibiting a 1,280-fold increase in resistance. To our knowledge, all of the mutations were novel, i.e., they have not been identified as beneficial by random mutagenesis or DNA shuffling or seen in any of the naturally occurring TEM β-lactamases, the most prevalent type of Gram-negative β-lactamases. This combined approach allows for the rapid improvement of any property that can be screened experimentally and provides a powerful broadly applicable tool for protein engineering.
- 1 May 2002
- Published by Wiley in Protein Science
- Vol. 11 (5) , 1218-1226
Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening
Granulocyte‐colony stimulating factor (G‐CSF) is used worldwide to prevent neutropenia caused by high‐dose chemotherapy. It has limited stability, strict formulation and storage requirements, and because of poor oral absorption must be administered by injection (typically daily). Thus, there is significant interest in developing analogs with improved pharmacological properties. We used our ultrahigh throughput computational screening method to improve the physicochemical characteristics of G‐CSF. Improving these properties can make a molecule more robust, enhance its shelf life, or make it more amenable to alternate delivery systems and formulations. It can also affect clinically important features such as pharmacokinetics. Residues in the buried core were selected for optimization to minimize changes to the surface, thereby maintaining the active site and limiting the designed protein's potential for antigenicity. Using a structure that was homology modeled from bovine G‐CSF, core designs of 25–34 residues were completed, corresponding to 1021–1028 sequences screened. The optimal sequence from each design was selected for biophysical characterization and experimental testing; each had 10–14 mutations. The designed proteins showed enhanced thermal stabilities of up to 13°C, displayed five‐to 10‐fold improvements in shelf life, and were biologically active in cell proliferation assays and in a neutropenic mouse model. Pharmacokinetic studies in monkeys showed that subcutaneous injection of the designed analogs results in greater systemic exposure, probably attributable to improved absorption from the subcutaneous compartment. These results show that our computational method can be used to develop improved pharmaceuticals and illustrate its utility as a powerful protein design tool.
- 1 May 2002
- Published by Wiley in Protein Science
- Vol. 11 (5) , 1218-1226
Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening
Granulocyte‐colony stimulating factor (G‐CSF) is used worldwide to prevent neutropenia caused by high‐dose chemotherapy. It has limited stability, strict formulation and storage requirements, and because of poor oral absorption must be administered by injection (typically daily). Thus, there is significant interest in developing analogs with improved pharmacological properties. We used our ultrahigh throughput computational screening method to improve the physicochemical characteristics of G‐CSF. Improving these properties can make a molecule more robust, enhance its shelf life, or make it more amenable to alternate delivery systems and formulations. It can also affect clinically important features such as pharmacokinetics. Residues in the buried core were selected for optimization to minimize changes to the surface, thereby maintaining the active site and limiting the designed protein's potential for antigenicity. Using a structure that was homology modeled from bovine G‐CSF, core designs of 25–34 residues were completed, corresponding to 1021–1028 sequences screened. The optimal sequence from each design was selected for biophysical characterization and experimental testing; each had 10–14 mutations. The designed proteins showed enhanced thermal stabilities of up to 13°C, displayed five‐to 10‐fold improvements in shelf life, and were biologically active in cell proliferation assays and in a neutropenic mouse model. Pharmacokinetic studies in monkeys showed that subcutaneous injection of the designed analogs results in greater systemic exposure, probably attributable to improved absorption from the subcutaneous compartment. These results show that our computational method can be used to develop improved pharmaceuticals and illustrate its utility as a powerful protein design tool.
- 1 June 1990
- Vol. 8 (8) , 18-24
Macromolecule structure determination using NMR data and molecular simulation techniques.
NMR graf utilizes molecular mechanics and molecular dynamics simulation techniques, in conjunction with NOE and J-coupling data from NMR experiments, to quickly derive and analyze candidate structures of macromolecules. Test cases produce results within the experimental error bars of structures derived using x-ray crystallography.
- 1 June 1990
- Vol. 8 (8) , 18-24
Macromolecule structure determination using NMR data and molecular simulation techniques.
NMR graf utilizes molecular mechanics and molecular dynamics simulation techniques, in conjunction with NOE and J-coupling data from NMR experiments, to quickly derive and analyze candidate structures of macromolecules. Test cases produce results within the experimental error bars of structures derived using x-ray crystallography.
- 31 July 1982
- Published by Elsevier in Behavioral and Neural Biology
- Vol. 35 (3) , 211-216
Evidence for a “consolidation” effect during changes in ocular dominance of cortical neurons in kittens
- 31 July 1982
- Published by Elsevier in Behavioral and Neural Biology
- Vol. 35 (3) , 211-216
Evidence for a “consolidation” effect during changes in ocular dominance of cortical neurons in kittens
- 1 February 1981
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 45 (2) , 254-266
Cortical recovery from effects of monocular deprivation: acceleration with norepinephrine and suppression with 6-hydroxydopamine.
- 1 February 1981
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 45 (2) , 254-266
Cortical recovery from effects of monocular deprivation: acceleration with norepinephrine and suppression with 6-hydroxydopamine.